Ampio Pharmaceuticals is Pharmaceuticals in United States that focus on Ampio Pharmaceuticals Inc business. Founded in 1996. They cover business area such as Ampio Pharmaceuticals Inc, advancement, immunology-base therapy, prevalent inflammatory condition, its lead product candidate, Ampion, clinical trial, severe Osteoarthritis, an intravenous treatment, an inhale treatment, respiratory distress.
1996
( 28 years old in 2024 )
Ampio Pharmaceuticals Inc
-
373 Inverness Parkway
Suite 200
Englewood, CO 80112
United States
Private
Ampio Pharmaceuticals Incadvancementimmunology-base therapyprevalent inflammatory conditionits lead product candidateAmpionclinical trialsevere Osteoarthritisan intravenous treatmentan inhale treatmentrespiratory distress
* We use standard office opening hours in near Ampio Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ampio Pharmaceuticals is Pharmaceuticals business from United States that founded in 1996 (28 years old in 2024), Ampio Pharmaceuticals business is focusing on Ampio Pharmaceuticals Inc.
Ampio Pharmaceuticals headquarter office and corporate office address is located in 373 Inverness Parkway Suite 200 Englewood, CO 80112 United States.
Ampio Pharmaceuticals was founded in United States.
In 2024, Ampio Pharmaceuticals is currently focus on Ampio Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Ampio Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ampio Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
